Claudia Riccardi is currently recipient of a postdoctoral fellowship granted by “Fondazione Umberto Veronesi”, under the supervision of Prof. Daniela Montesarchio. She obtained her degree with honors at the age of 23 in Chemistry and Pharmaceutical Technologies at Federico II University of Naples in 2013. She got her Ph.D. in Chemical Sciences in 2017 and then continued her research activities under the supervision of Prof. Montesarchio with fellowships granted by AIRC (Italian Association for the Research on Cancer). Her research interests are mainly devoted to the design, synthesis, and characterization of Ru(III) and Pt(II) complexes as potential anticancer compounds, as well as G-quadruplex-forming aptamers with potential anticancer or anticoagulant properties. She also studied multifunctional nanosystems incorporating anticancer metal-based drugs and/or aptamers for theranostic applications. She was recipient of the “Salvatore Venuta fellowship 2019” prize in Nanomedicine and of two “Best PhD thesis” prizes. She is coauthor of 32 scientific articles published in the period 2015–2021 in international, peer‐review journals, and of ca. 20 oral and poster communications presented at international and national conferences.

Best Invited Lecture

- Beatriz Berzal-Herranz, Cristina Romero-López et al., "The 3’UTR of WNV genome is an excellent target for antiviral drugs".

Alfredo Berzal-Herranz received his PhD in Molecular Biology from the Autónoma University of Madrid (1990). After a brief stay at the Department of Microbiology, of the University of Uppsala (Sweden), he moved to the Department of Microbiology, College of Medicine of the University of Vermont (USA). In 1993 he returned to Spain, joining the Instituto de Parasitología y Biomedicina “López-Neyra” (IPBLN), located in the city of Granada. The IPBLN belongs to the Spanish National Research Council (CSIC), where he established his own research group and chaired the Department of Molecular Biology. From November 2005 to March 2014 was the Director of the Institute (IPBLN-CSIC). He is the author of about 100 research articles and book chapters and has edited four special research issues. He is or has been a member of the Editorial Board of more than 15 research journals. His research group is currently interested in understanding the structure/function relationship of viral RNA genomes. He is pursuing the identification of the molecular mechanisms used by the RNA viruses to store all necessary genetic information and studying the potential use of genomic RNA structural domains as potential antiviral targets. In addition, his group is interested in the design and characterization of antiviral RNA molecules (Aptamers, antisense, ribozymes).

Cristina Romero-López received her PhD degree in Biochemistry and Molecular Biology by the University of Granada in Nov 2005. The thesis project was focused on developing new RNA-based tools able to interfere with the hepatitis C virus translation. An additional point was to make use of these compounds as molecular tools with the aim of studying the functionality of conserved regions in viral RNA genomes. Since then, she has been working as post-doctoral researcher in the Dr. Berzal-Herranz’s lab, in the Instituto de Parasitología y Biomedicina “López-Neyra” (IPBLN), located in the city of Granada (Spain). Throughout these years, her scientific interest has been focused in the RNA structural biology, moving from the research with small catalytic RNA molecules to current investigations about the functionality of conserved structural domains in viral RNA genomes, as well as their implications in virus progression and infectivity. These studies have promoted the implementation of complex high-throughput techniques for the analysis of the RNA folding. During her scientific career she has participated in eighteen research projects, supported by different national and international agencies. She has published around 50 research manuscripts and book chapters, as well as around 80 communications in national and international meetings. She has supervised six master theses and four graduate theses. Currently, she is a member of the editorial board of different research journals.

One free 1-day hands on/testing using microwaves offered by Microwave Technologies Consulting

- Marc Le Borgne et al., "Triazole-indole hybrid molecules as antifungal agents: Design, synthesis and biological activity, and beyond".

Marc Le Borgne obtained his Ph.D. in medicinal chemistry under the supervision of Prof. Guillaume Le Baut at the University of Nantes (France) in 1997. He began his research and academic career in the School of Pharmacy at the University of Nantes. In 2008, he moved to the Université Claude Bernard Lyon 1 as a full professor in medicinal chemistry. He is currently a researcher in the Team Small Molecules for Biological Targets (Cancer Research Center of Lyon). His research interests focus on the design and synthesis of bioactive small molecules as anti-infective compounds or kinase-targeted anticancer therapeutic agents. Collaborative work remains at the heart of his quality research work.

One registration seat to an upcoming Simulations Plus workshop

- Radu Tamaian et al., "Rational design of new antipsychotic virtual derivatives with improved ADMET properties and high binding activity".

Principal Investigator at the National Institute for Research and Development for Cryogenic and Isotopic Technologies – ICSI Rm. Vâlcea. My expertise is in bioinformatics and cheminformatics, with a wide research area including computer-aided drug design (CADD), computational (eco)toxicology, in silico nutrigenomics, and blockchain-enabled healthcare. Outside the lab, as the National Contact Point (NCP), I was involved in coordination and support actions for the EU research infrastructures (included in the ESFRI Roadmap) during The 7th Framework Programme of the European Commission.

Hielscher Ultrasonics GmbH: High-power ultrasonic processors for liquid processing

Hielscher Ultrasonics specializes in the design, development and production of ultrasonic devices - both for use in laboratories as well as for industrial applications. Due to the outstanding power of the ultrasonic processors and the high quality standards, Hielscher became the world's leading supplier of high performance ultrasonic equipment. The product range of Hielscher Ultrasonics includes ultrasonic devices to / for

Helping laboratories to achieve their goals and improve their workflow by providing them with the smartest possible solutions. That is what drives Analis. Thanks to its broad range of lab equipment and lab furniture, Analis can offer both global and integrated solutions in line with your needs. Whether pharma, life science, cell analysis, chemical, medical in vitro diagnosis and industrial QC/QA or R&D, its team of specialists injects its expertise into your applications. A level of professionalism that is also reflected in its after-sales service, application support, technical maintenance and follow-up in its daily quest to secure your satisfaction.

The International Natural Product Sciences Taskforce (INPST) represents an open innovation platform bringing together scientists and key opinion leaders of the natural product scientific research field, as well as members of multiple scientific excellence centers and pharmaceutical-, biotech-, healthtech-, and natural product-related industries.

A pioneer in scholarly open access publishing, MDPI has supported academic communities since 1996. Based in Basel, Switzerland, MDPI has the mission to foster open scientific exchange in all forms, across all disciplines. Our 331 diverse, peer-reviewed, open access journals are supported by more than 84,200 academic editors. We serve scholars from around the world to ensure the latest research is freely available and all content is distributed under a Creative Commons Attribution License (CC BY).

Serving clients worldwide for 25 years, Simulations Plus, Inc., is a leading provider of modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions.

Eurisotop, a wholly owned subsidiary of Cambridge Isotope Laboratories, Inc. (CIL), was founded in January 1991 by a group of researchers from the Commissariat à l’Energie Atomique (CEA). Since its acquisition by CIL in 2001, Eurisotop has become a leading producer of deuterated solvents and is the leading supplier of stable isotope-labelled compounds in Europe.

Pharmaceuticals (ISSN 1424-8247; CODEN: PHARH2) is a peer-reviewed open access journal of medicinal chemistry and related drug sciences, published monthly online by MDPI. The Swiss Chemical Society (SCS) and Academy of Pharmaceutical Sciences (APS) are partners of Pharmaceuticals and their members receive a discount on the article processing charge.

Microwave Technologies Consulting (MTC) specialises in research & process development, and equipment design using microwave (915 MHz, 2.45 GHz and 5.8 GHz) processing technology for applications in the field of biotech, food technology, nanotechnology, medical technology, and the chemical and pharmaceutical industries.